The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo

[1]  David B. Witonsky,et al.  SNP discovery, expression and cis-regulatory variation in the UGT2B genes , 2011, The Pharmacogenomics Journal.

[2]  David B. Witonsky,et al.  Allelic imbalance (AI) identifies novel tissue‐specific cis‐regulatory variation for human UGT2B15 , 2010, Human mutation.

[3]  Yasuhiro Aoki,et al.  Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers , 2009, Drug Metabolism and Disposition.

[4]  S. Ohno,et al.  Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction , 2009, Drug Metabolism and Disposition.

[5]  R. Fujiwara,et al.  Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines , 2008, Drug Metabolism and Disposition.

[6]  Wei Zhang,et al.  Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene , 2008, Pharmacogenetics and genomics.

[7]  M. Nakajima,et al.  Genetic polymorphisms in the 5′-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation , 2008, Pharmacogenetics and genomics.

[8]  I. Jang,et al.  Pharmacokinetic and Pharmacodynamic Interaction of Lorazepam and Valproic Acid in Relation to UGT2B7 Genetic Polymorphism in Healthy Subjects , 2008, Clinical pharmacology and therapeutics.

[9]  P. Marquet,et al.  Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients , 2007, Pharmacogenetics and genomics.

[10]  T. Habuchi,et al.  Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients , 2007, European Journal of Clinical Pharmacology.

[11]  R. Remmel,et al.  Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer , 2006, Oncogene.

[12]  C. Guillemette,et al.  Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. , 2005, Pharmacogenetics and genomics.

[13]  Yannick Duguay,et al.  A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity , 2004, Clinical pharmacology and therapeutics.

[14]  M. Ratain,et al.  UGT pharmacogenomics: implications for cancer risk and cancer therapeutics. , 2003, Pharmacogenetics.

[15]  S. Kaasa,et al.  Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy , 2002, European Journal of Clinical Pharmacology.

[16]  Walter E. Gall,et al.  Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7 , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  Yannick Duguay,et al.  Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. , 2006, Cancer research.

[18]  S. Kaasa,et al.  Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients , 2003, The Pharmacogenomics Journal.

[19]  C. Guillemette.  Pharmacogenomics of human UDP-glucuronosyltransferase enzymes , 2003, The Pharmacogenomics Journal.

[20]  S. Kaasa,et al.  Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients , 2003, The Pharmacogenomics Journal.

[21]  D. Hum,et al.  Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. , 2001, Endocrinology.

[22]  R. Tukey,et al.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.

[23]  T. Tephly,et al.  Human UGT2B7 catalyzes morphine glucuronidation. , 1997, Drug metabolism and disposition: the biological fate of chemicals.